Positive News SentimentPositive NewsNASDAQ:XWEL XWELL (XWEL) Stock Forecast, Price & News $0.26 -0.01 (-3.70%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$0.26▼$0.2850-Day Range$0.23▼$0.3452-Week Range$0.22▼$1.20Volume99,319 shsAverage Volume156,425 shsMarket Capitalization$21.69 millionP/E RatioN/ADividend YieldN/APrice Target$1.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media XWELL MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside284.6% Upside$1.00 Price TargetShort InterestBearish1.79% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$12,500 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.01 out of 5 starsMedical Sector779th out of 987 stocksPersonal Services Industry11th out of 13 stocks 3.5 Analyst's Opinion Consensus RatingXWELL has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.00, XWELL has a forecasted upside of 284.6% from its current price of $0.26.Amount of Analyst CoverageXWELL has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted1.79% of the float of XWELL has been sold short.Short Interest Ratio / Days to CoverXWELL has a short interest ratio ("days to cover") of 8.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldXWELL does not currently pay a dividend.Dividend GrowthXWELL does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for XWEL. Previous Next 2.7 News and Social Media Coverage News SentimentXWELL has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for XWELL this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for XWEL on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added XWELL to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, XWELL insiders have bought more of their company's stock than they have sold. Specifically, they have bought $12,500.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.30% of the stock of XWELL is held by insiders.Percentage Held by InstitutionsOnly 10.85% of the stock of XWELL is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of XWELL is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of XWELL is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioXWELL has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About XWELL (NASDAQ:XWEL) StockXWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Treat, and Corporate and Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Treat segment consists of access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.Read More Receive XWEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for XWELL and its competitors with MarketBeat's FREE daily newsletter. Email Address XWEL Stock News HeadlinesMay 20, 2023 | americanbankingnews.comQ2 2023 Earnings Estimate for XWELL, Inc. Issued By HC Wainwright (NASDAQ:XWEL)May 16, 2023 | finance.yahoo.comQ1 2023 XWELL Inc Earnings CallJune 10, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.May 15, 2023 | finance.yahoo.comXWELL, Inc. Reports First Quarter 2023 ResultsMay 11, 2023 | marketwatch.comGlobal Spot Welding Machine For Lithium Battery Market Size 2023-2031 Business Strategies by Absolute Reports | with [101 Pages]May 11, 2023 | finance.yahoo.comXWELL, Inc. to Announce First Quarter 2023 Financial Results on Monday, May 15May 4, 2023 | finance.yahoo.comXWELL, Inc. Names Valerie Lightfoot Chief Financial OfficerMay 3, 2023 | finance.yahoo.comXWELL Unveils Automated Massage Chairs at XpresSpa Locations Across the U.S.June 10, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.May 3, 2023 | americanbankingnews.comRover Group (NASDAQ:ROVR) versus XWELL (NASDAQ:XWEL) Head to Head ContrastApril 27, 2023 | finance.yahoo.comXWELL, Inc. Granted 180-Day Extension by NASDAQ to Regain Compliance with Minimum Bid Price RuleApril 19, 2023 | marketwatch.comXwell 2022 Revenue Drops Amid Covid-19 Testing Site ClosuresApril 19, 2023 | finance.yahoo.comRevenues Working Against XWELL, Inc.'s (NASDAQ:XWEL) Share PriceApril 18, 2023 | msn.comHC Wainwright & Co. Reiterates XWELL (XWEL) Buy RecommendationApril 18, 2023 | benzinga.comXWELL shares are trading lower after the company reported FY22 financial results.April 18, 2023 | benzinga.comXWELL Earnings Perspective: Return On Capital EmployedApril 18, 2023 | markets.businessinsider.comAnalysts Offer Insights on Services Companies: XWELL (XWEL) and Vertex Energy (VTNR)April 18, 2023 | finance.yahoo.comQ4 2022 XWELL Inc Earnings CallApril 17, 2023 | finance.yahoo.comXWELL, Inc. Reports Fiscal Year 2022 ResultsApril 14, 2023 | finance.yahoo.comXWELL, Inc. to Announce 2022 Financial Results on Monday April 17April 12, 2023 | americanbankingnews.comCritical Contrast: XWELL (NASDAQ:XWEL) vs. CVS Group (OTCMKTS:CVSGF)April 8, 2023 | americanbankingnews.comQ1 2023 EPS Estimates for XWELL, Inc. (NASDAQ:XWEL) Increased by HC WainwrightApril 6, 2023 | marketwatch.com2023-2030 Battery Cell Charge and Discharge Tester Market Size and Recent Developments | Research Report by Absolute ReportsApril 4, 2023 | markets.businessinsider.comXWELL (XWEL) Receives a Buy from H.C. WainwrightApril 4, 2023 | americanbankingnews.comHC Wainwright Lowers XWELL (NASDAQ:XWEL) Price Target to $1.00March 30, 2023 | finance.yahoo.comXWELL Announces Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K And Provides Preliminary FY2022 Operating UpdateMarch 30, 2023 | americanbankingnews.comContrasting Cannabis Sativa (OTCMKTS:CBDS) and XWELL (NASDAQ:XWEL)See More Headlines XWEL Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XWEL Company Calendar Last Earnings4/17/2023Today6/10/2023Next Earnings (Estimated)8/21/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Personal services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:XWEL CUSIPN/A CIK1410428 Webwww.xwell.com Phone(212) 750-9595Fax309-410-3967EmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Forecast$1.00 High Stock Price Forecast$1.00 Low Stock Price Forecast$1.00 Forecasted Upside/Downside+284.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-32,840,000.00 Net Margins-87.44% Pretax Margin-91.50% Return on Equity-58.73% Return on Assets-42.66% Debt Debt-to-Equity RatioN/A Current Ratio4.41 Quick Ratio4.30 Sales & Book Value Annual Sales$55.94 million Price / Sales0.39 Cash FlowN/A Price / Cash FlowN/A Book Value$0.51 per share Price / Book0.51Miscellaneous Outstanding Shares83,420,000Free Float81,500,000Market Cap$21.69 million OptionableOptionable Beta2.01 Key ExecutivesScott R. MilfordPresident, Chief Executive Officer & DirectorOmar A. HaynesChief Financial OfficerDavid KohelChief Technology OfficerCara SofferSenior Vice President & General CounselTesh RamsarupDirector-Operation ServicesKey CompetitorsMEDIROM Healthcare TechnologiesNYSE:MRMContext TherapeuticsNASDAQ:CNTXZhongchaoNASDAQ:ZCMDAcer TherapeuticsNASDAQ:ACERLiminal BioSciencesNASDAQ:LMNLView All CompetitorsInsiders & InstitutionsRobert WeinsteinBought 25,000 shares on 5/30/2023Total: $6,250.00 ($0.25/share)Robert WeinsteinBought 25,000 shares on 5/26/2023Total: $6,250.00 ($0.25/share)Geode Capital Management LLCBought 1,041,547 shares on 5/16/2023Ownership: 1.249%BlackRock Inc.Bought 1,847,881 shares on 5/12/2023Ownership: 2.215%Group One Trading L.P.Bought 5,200 shares on 5/12/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions XWEL Stock - Frequently Asked Questions Should I buy or sell XWELL stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for XWELL in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" XWEL shares. View XWEL analyst ratings or view top-rated stocks. What is XWELL's stock price forecast for 2023? 1 analysts have issued 12 month target prices for XWELL's stock. Their XWEL share price forecasts range from $1.00 to $1.00. On average, they expect the company's share price to reach $1.00 in the next year. This suggests a possible upside of 284.6% from the stock's current price. View analysts price targets for XWEL or view top-rated stocks among Wall Street analysts. How have XWEL shares performed in 2023? XWELL's stock was trading at $0.3629 at the start of the year. Since then, XWEL shares have decreased by 28.4% and is now trading at $0.26. View the best growth stocks for 2023 here. When is XWELL's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023. View our XWEL earnings forecast. How were XWELL's earnings last quarter? XWELL, Inc. (NASDAQ:XWEL) announced its earnings results on Monday, April, 17th. The company reported ($0.15) earnings per share for the quarter. The company had revenue of $7.56 million for the quarter. XWELL had a negative trailing twelve-month return on equity of 58.73% and a negative net margin of 87.44%. What is XWELL's stock symbol? XWELL trades on the NASDAQ under the ticker symbol "XWEL." Who are XWELL's major shareholders? XWELL's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (2.22%), Geode Capital Management LLC (1.25%), Integrated Wealth Concepts LLC (0.25%), Bank of New York Mellon Corp (0.11%) and Group One Trading L.P. (0.00%). Insiders that own company stock include Bruce Bernstein, Robert Weinstein and Scott R Milford. View institutional ownership trends. How do I buy shares of XWELL? Shares of XWEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is XWELL's stock price today? One share of XWEL stock can currently be purchased for approximately $0.26. How much money does XWELL make? XWELL (NASDAQ:XWEL) has a market capitalization of $21.69 million and generates $55.94 million in revenue each year. The company earns $-32,840,000.00 in net income (profit) each year or ($0.38) on an earnings per share basis. How can I contact XWELL? XWELL's mailing address is 254 WEST 31ST STREET 11TH FLOOR, NEW YORK NY, 10001. The official website for the company is www.xwell.com. The company can be reached via phone at (212) 750-9595, via email at ir@xpresspagroup.com, or via fax at 309-410-3967. This page (NASDAQ:XWEL) was last updated on 6/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XWELL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.